Vascular dementia

被引:201
作者
Korczyn, Amos D. [2 ]
Vakhapova, Veronika
Grinberg, Lea T. [1 ,3 ]
机构
[1] Univ Calif San Francisco, Memory & Aging Ctr, Dept Neurol, San Francisco, CA 94143 USA
[2] Tel Aviv Univ, Sackler Sch Med, Ramat Aviv, Israel
[3] Univ Sao Paulo, Sch Med, Aging Brain Study Grp, Dept Pathol, BR-05508 Sao Paulo, Brazil
关键词
Vascular; Dementia; Stroke; Diagnosis; Neuropathology; Biomarkers; Cognitive impairment; BLOOD-BRAIN-BARRIER; COGNITIVE IMPAIRMENT; ALZHEIMER-DISEASE; RISK-FACTORS; METABOLIC SYNDROME; CLINICAL-CRITERIA; MIXED DEMENTIA; STROKE; POPULATION; DIAGNOSIS;
D O I
10.1016/j.jns.2012.03.027
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
The epidemic growth of dementia causes great concern for the society. It is customary to consider Alzheimer's disease (AD) as the most common cause of dementia, followed by vascular dementia (VaD). This dichotomous view of a neurodegenerative disease as opposed to brain damage caused by extrinsic factors led to separate lines of research in these two entities. Indeed, accumulated data suggest that the two disorders have additive effects and probably interact; however it is still unknown to what degree. Furthermore, epidemiological studies have shown "vascular" risk factors to be associated with AD. Therefore, a clear distinction between AD and VaD cannot be made in most cases, and is furthermore unhelpful. In the absence of efficacious treatment for the neurodegenerative process, special attention must be given to the vascular component, even in patients with presumed mixed pathology. Symptomatic treatment of VaD and AD is similar, although the former is less effective. For prevention of dementia it is important to treat all factors aggressively, even in stroke survivors who do not show evidence of cognitive decline. In this review, we will give a clinical and pathological picture of the processes leading to VaD and discuss its interaction with AD. (c) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:2 / 10
页数:9
相关论文
共 126 条
[1]
Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis [J].
Abboud, Sherine ;
Viiri, Leena E. ;
Luetjohann, Dieter ;
Goebeler, Sirkka ;
Luoto, Teemu ;
Friedrichs, Silvia ;
Desfontaines, Philippe ;
Gazagnes, Marie-dominique ;
Laloux, Patrice ;
Peeters, Andre ;
Seeldrayers, Pierrette ;
Lehtimaki, Terho ;
Karhunen, Pekka ;
Pandolfo, Massimo ;
Laaksonen, Reijo .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2008, 16 (08) :955-960
[2]
Natural history of dementia associated with lacunar infarctions [J].
Aharon-Peretz, J ;
Daskovski, E ;
Mashiach, T ;
Tomer, R .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 203 :53-55
[3]
Stroke Treatment Academic Industry Roundtable (STAIR) Recommendations for Maximizing the Use of Intravenous Thrombolytics and Expanding Treatment Options With Intra-arterial and Neuroprotective Therapies [J].
Albers, Gregory W. ;
Goldstein, Larry B. ;
Hess, David C. ;
Wechsler, Lawrence R. ;
Furie, Karen L. ;
Gorelick, Philip B. ;
Hurn, Patty ;
Liebeskind, David S. ;
Nogueira, Raul G. ;
Saver, Jeffrey L. .
STROKE, 2011, 42 (09) :2645-2650
[4]
Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915
[5]
[Anonymous], ICD 10 CLASS MENT BE
[6]
[Anonymous], 1994, DIAGN STAT MAN MENT, VFourth, P143
[7]
Galantamine treatment of vascular dementia: A randomized trial [J].
Auchus, A. P. ;
Brashear, H. R. ;
Salloway, S. ;
Korczyn, A. D. ;
De Deyn, P. P. ;
Gassmann-Mayer, C. .
NEUROLOGY, 2007, 69 (05) :448-458
[8]
Balash Yacov, 2007, Handb Clin Neurol, V84, P417, DOI 10.1016/S0072-9752(07)84052-8
[9]
Beeri Michal Schnaider, 2009, Dialogues Clin Neurosci, V11, P201
[10]
Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease [J].
Bell, Robert D. ;
Zlokovic, Berislav V. .
ACTA NEUROPATHOLOGICA, 2009, 118 (01) :103-113